Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Juan Pasquau"'
Autor:
Laura Morata Ruiz, Alessandro Ruggieri, Marco Falcone, Juan Pasquau Liaño, Ivan Gentile, Miguel Salavert Lletí, Leonor Moreno Núñez, Antonio Cascio, Carlo Tascini, Maria Loeches Yagüe, Francesco Giuseppe De Rosa, Alessandra Ori, Alessandro Comandini, Agnese Cattaneo, Paolo Antonio Grossi
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 36, Iss , Pp 200-209 (2024)
Objectives: To retrospectively describe the patterns of use of dalbavancin for treating infections in diabetic patients in Italian and Spanish standard clinical practice. Methods: DALBADIA [NCT04959799] was a multicentre, observational, retrospective
Externí odkaz:
https://doaj.org/article/2e23e12e4a3045e091cbc102aeb40ba9
Autor:
Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis López-Cortés, Alicia Gutiérrez, Jesús Santos, Francisco Téllez, Mohamed Omar, Sergio Ferra-Murcia, Elisa Fernández, Rosario Javier, Coral García-Vallecillos, Juan Pasquau
Publikováno v:
Viruses, Vol 16, Iss 2, p 259 (2024)
The continuous pharmacological advances in antiretroviral treatment (ART) and the increasing understanding of HIV drug resistance has led to a change in the paradigm of ART optimization in the setting of the viral suppression of treatment-experienced
Externí odkaz:
https://doaj.org/article/2e2eeeff682a4538bc7096d75b4e4eae
Autor:
Svetlana Sadyrbaeva-Dolgova, Ricardo García-Fumero, Manuela Exposito-Ruiz, Juan Pasquau-Liaño, Alberto Jiménez-Morales, Carmen Hidalgo-Tenorio
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Colistimethate sodium (CMS) is the inactive prodrug of colistin, CMS has a narrow antibacterial spectrum with concentration-dependent bactericidal activity against multidrug-resistant gram-negative bacteria, including Pseudomonas aeruginosa
Externí odkaz:
https://doaj.org/article/bdd44f0e7d0a4ac18c8138844a308ea1
Autor:
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, Alfonso Cabello, Mario Fernández-Ruiz, Pedro Pérez-Segura, Jesús San Román, Juan Berenguer, Raúl Córdoba, Rafael Delgado, Pedro Pablo España, Ignacio Alberto Gómez-Centurión, Juan María González del Castillo, Sarah Béatrice Heili, Francisco Javier Martínez-Peromingo, Rosario Menéndez, Santiago Moreno, José Luís Pablos, Juan Pasquau, José Luis Piñana, on behalf of the MODUS Investigators (Adenda)
Publikováno v:
Viruses, Vol 15, Iss 7, p 1449 (2023)
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The evolution to less aggressive but better-transmitted viral variants, and
Externí odkaz:
https://doaj.org/article/45b1da184dad45e39a6e9199a97d3d53
Autor:
Carmen Hidalgo-Tenorio, David Vinuesa, Coral García-Vallecillos, Leopoldo Muñoz-Medina, Sergio Sequera, Rosario Javier, Miguel Ángel López-Ruz, Svetlana Sadyrbaeva-Dolgova, Juan Pasquau
Publikováno v:
Viruses, Vol 14, Iss 12, p 2626 (2022)
Two-drug regimens (2DRs) are emerging in clinical practice guidelines as treatment option for both naive and treatment-experienced people living with HIV (PLHIV). Objectives: To determine the real-life effectiveness of 2DR with 25 mg RPV plus 50 mg D
Externí odkaz:
https://doaj.org/article/ca0738d9b9ec405e9150637edeacdf06
Autor:
Carmen Hidalgo-Tenorio, David Vinuesa, Antonio Plata, Pilar Martin Dávila, Simona Iftimie, Sergio Sequera, Belén Loeches, Luis Eduardo Lopez-Cortés, Mari Carmen Fariñas, Concepción Fernández-Roldan, Rosario Javier-Martinez, Patricia Muñoz, Maria del Mar Arenas-Miras, Francisco Javier Martínez-Marcos, Jose Maria Miró, Carmen Herrero, Elena Bereciartua, Samantha E. De Jesus, Juan Pasquau
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 18, Iss 1, Pp 1-10 (2019)
Abstract Objectives To analyse the effectiveness of dalbavancin (DBV) in clinical practice as consolidation therapy in patients with bloodstream infection (BSI) and/or infective endocarditis (IE) produced by gram-positive cocci (GPC), as well as its
Externí odkaz:
https://doaj.org/article/d09ea701443848fc988892fd252d8c0a
Autor:
Svetlana Sadyrbaeva-Dolgova, Pilar Aznarte-Padial, Juan Pasquau-Liaño, Manuela Expósito-Ruiz, Miguel Ángel Calleja Hernández, Carmen Hidalgo-Tenorio
Publikováno v:
International Journal of Infectious Diseases, Vol 85, Iss , Pp 80-87 (2019)
Objective: The aim of this study was to evaluate the safety and efficacy of de-escalation in patients under treatment with carbapenems and its impact on clinical outcomes. Methods: A prospective observational study was conducted for 1 year. Patients
Externí odkaz:
https://doaj.org/article/a5e700fd004046b78cfd4746ee02b1ad
Autor:
Juan Pasquau, Samantha E. de Jesus, Piedad Arazo, María J. Crusells, María J. Ríos, Fernando Lozano, Javier de la Torre, María J. Galindo, Jorge Carmena, Jesús Santos, Carlos Tornero, Guillermo Verdejo, Gloria Samperiz, Zaira Palacios, Carmen Hidalgo-Tenorio, on behalf of the RIDAR Study Group
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The objective was to analyze the effectiveness and safety of dual therapy with rilpivirine plus boosted-darunavir (RPV + bDRV) in real-life patients. Methods Observational, retrospective, multi-center study in HIV+ patients who ha
Externí odkaz:
https://doaj.org/article/8399ff5a99754d8fa8099e23f2a15e29
Autor:
Carmen Hidalgo-Tenorio, Carmen Maria García-Martínez, Juan Pasquau, Mohamed Omar-Mohamed-Balgahata, Miguel López-Ruz, Javier López-Hidalgo, Concepción Gil-Anguita
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0245870 (2021)
BackgroundThe objective of this study in MSM living with HIV was to determine the incidence of HSIL and ASCC, related factors, and the response to treatment.Patients and methodsData were gathered in 405 consecutive HIV-infected MSM (May 2010-December
Externí odkaz:
https://doaj.org/article/2f428b1057e040c092f2578d62b5e25c
Autor:
Carmen Hidalgo-Tenorio, Juan Pasquau, David Vinuesa, Sergio Ferra, Alberto Terrón, Isabel SanJoaquín, Antoni Payeras, Onofre Juan Martínez, Miguel Ángel López-Ruz, Mohamed Omar, Javier de la Torre-Lima, Ana López-Lirola, Jesús Palomares, José Ramón Blanco, Marta Montero, Coral García-Vallecillos
Publikováno v:
Viruses, Vol 14, Iss 3, p 524 (2022)
Brief: Real-world data in naïve HIV-1 patients demonstrate that dolutegravir plus lamivudine in a multiple tablet regimen is effective, safe, and satisfactory; it causes moderately increasing weight and abdominal circumference and is administrable o
Externí odkaz:
https://doaj.org/article/02c24f3364554c839d1450d7d52e2edd